Predicting survival in non-small-cell lung cancer using positron emission tomography: several conclusions from multiple comparisons

Affiliations

¹ University of Pennsylvania Perelman School of Medicine, Philadelphia, PA abigail.berman@uphs.upenn.edu.
² University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Comment

Abigail T Berman et al. J Clin Oncol. 2014.

. 2014 May 20;32(15):1631-2.

doi: 10.1200/JCO.2013.54.3074. Epub 2014 Apr 21.

¹ University of Pennsylvania Perelman School of Medicine, Philadelphia, PA abigail.berman@uphs.upenn.edu.
² University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

No abstract available

Comment on

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
Machtay M, Duan F, Siegel BA, Snyder BS, Gorelick JJ, Reddin JS, Munden R, Johnson DW, Wilf LH, DeNittis A, Sherwin N, Cho KH, Kim SK, Videtic G, Neumann DR, Komaki R, Macapinlac H, Bradley JD, Alavi A. Machtay M, et al. J Clin Oncol. 2013 Oct 20;31(30):3823-30. doi: 10.1200/JCO.2012.47.5947. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043740 Free PMC article. Clinical Trial.